Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Liver Diseases

Free Subscription Articles published in Gastroenterology Retrieve available abstracts of 255 articles: HTML format

Single Articles

May 2024
1. NIEMI NM, Debosch BJ
   Survival of the Fittest: Clonal Selection of Somatic Mutations Reveals Targets to Abate Chronic Liver Injury.
   Gastroenterology. 2024;166:936-937.
   PubMed    
   
   
   
2. GEORGE B, Kudryashova O, Kravets A, Thalji S, et al
   Transcriptomic-Based Microenvironment Classification Reveals Precision Medicine Strategies for Pancreatic Ductal Adenocarcinoma.
   Gastroenterology. 2024;166:859-871.
   PubMed     Abstract available
   
   
   
3. SCHONAUER R, Sierks D, Boerrigter M, Jawaid T, et al
   Sex, Genotype, and Liver Volume Progression as Risk of Hospitalization Determinants in Autosomal Dominant Polycystic Liver Disease.
   Gastroenterology. 2024;166:902-914.
   PubMed     Abstract available
   
   
   April 2024
4. WANG L, Berger NA, Kaelber DC, Xu R, et al
   Association of GLP-1 receptor agonists and hepatocellular carcinoma incidence and hepatic decompensation in patients with type 2 diabetes.
   Gastroenterology. 2024 Apr 29:S0016-5085(24)00494.
   PubMed     Abstract available
   
   
   
5. JIANG C, Lian M, Ma X
   A Rare Case Mimicking Congenital Hepatic Fibrosis.
   Gastroenterology. 2024 Apr 23:S0016-5085(24)00483.
   PubMed    
   
   
   March 2024
6. CAMPANI C, Guido M, Marra F
   Elusive hepatic nodules.
   Gastroenterology. 2024 Mar 23:S0016-5085(24)00355.
   PubMed    
   
   
   
7. HOLTZ LR, DeBosch BJ
   Deploying Lactulose as a Prebiotic to Reduce Complications of Chronic Liver Disease.
   Gastroenterology. 2024;166:534-535.
   PubMed    
   
   
   
8. URIAS E, Tedesco NR, Oliveri A, Raut C, et al
   PNPLA3 Risk Allele Association With ALT Response to Semaglutide Treatment.
   Gastroenterology. 2024;166:515-517.
   PubMed    
   
   
   
9. GAO F, Seto WK, Zheng MH
   Preventing Overdiagnosis of Nonalcoholic Fatty Liver Disease: Established Cutoff Values for Transient Elastography Are Needed.
   Gastroenterology. 2024;166:541-542.
   PubMed    
   
   
   
10. AN T, Liu L, Li X
    Factors Associated With the Influence of Liver Fibrosis Should Be Fully Considered.
    Gastroenterology. 2024;166:540-541.
    PubMed    
    
    
    February 2024
11. WONG RJ, Yang Z, Cheung R, Singal AK, et al
    Impact of Longitudinal Alcohol Use Patterns on Long-Term Risk of Cirrhosis Among U.S. Veterans with Steatotic Liver Disease.
    Gastroenterology. 2024 Feb 28:S0016-5085(24)00238.
    PubMed     Abstract available
    
    
    
12. CHEN J, Feng W, Sun M, Huang W, et al
    TGF-beta1 Induced SOX18 Elevation Promotes Hepatocellular Carcinoma Progression and Metastasis through Transcriptionally Upregulating PD-L1 and CXCL12.
    Gastroenterology. 2024 Feb 26:S0016-5085(24)00187.
    PubMed     Abstract available
    
    
    
13. ALLEN AM, Pose E, Reddy KR, Russo MW, et al
    Nonalcoholic Fatty Liver Disease Gets Renamed as Metabolic Dysfunction-Associated Steatotic Liver Disease: Progress But With Challenges.
    Gastroenterology. 2024;166:229-234.
    PubMed    
    
    
    
14. WALAYAT S, Pfau P
    2 AM in the Intensive Care Unit: What Could Go Wrong?
    Gastroenterology. 2024;166:e13-e15.
    PubMed    
    
    
    
15. BILAL M, Steinberg J, Louissaint J, Phan J, et al
    First Year on the Job as a Gastroenterologist and Hepatologist: Lessons Learned.
    Gastroenterology. 2024 Feb 1:S0016-5085(24)00125.
    PubMed    
    
    
    January 2024
16. POSE E, Piano S, Juanola A, Gines P, et al
    HEPATORENAL SYNDROME IN CIRRHOSIS.
    Gastroenterology. 2024 Jan 19:S0016-5085(24)00054.
    PubMed     Abstract available
    
    
    
17. LAURIDSEN MM, Gronkjaer LL, Khraibut S, Patel N, et al
    The multi-dimensional challenge of poor oral health in cirrhosis - disparities and solutions.
    Gastroenterology. 2024 Jan 13:S0016-5085(24)00043.
    PubMed    
    
    
    
18. MULLISH BH
    Risk Factors for Liver Cancer and Chronic Liver Disease-related Death: Are Sugar Substitutes Better Than the Real Thing?
    Gastroenterology. 2024;166:213-214.
    PubMed    
    
    
    
19. ZENG Q, Wu D, Tang H
    A Mysterious Abdominal Pain.
    Gastroenterology. 2024;166:27-30.
    PubMed    
    
    
    December 2023
20. MEZZACAPPA C, Bhat M
    Proteomic Panels for Alcohol-Associated Liver Disease: Accurate, but Different Enough From Existing Clinical Tests?
    Gastroenterology. 2023;165:1576.
    PubMed    
    
    
    November 2023
21. GARCIA-TSAO G, Abraldes JG, Rich NE, Wong VW, et al
    AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review.
    Gastroenterology. 2023 Nov 17:S0016-5085(23)05143.
    PubMed     Abstract available
    
    
    
22. KOJIMA H, Kadono K, Hirao H, Dery KJ, et al
    T Cell CEACAM1-TIM-3 Crosstalk Alleviates Liver Transplant Injury in Mice and Humans.
    Gastroenterology. 2023;165:1233-1248.
    PubMed     Abstract available
    
    
    
23. PENA-SANCHEZ JN, Osei JA, Teucher U, Tremblay M, et al
    Working With Indigenous Community and Patient Partners Is Essential to Advance Gastroenterology and Hepatology Research: Perspectives From Canada.
    Gastroenterology. 2023;165:1097-1101.
    PubMed    
    
    
    
24. LLOVET JM, Heikenwalder M
    Atezolizumab Plus Bevacizumab in Advanced HCC: Efficacy in NASH-Specific Etiology.
    Gastroenterology. 2023;165:1308-1310.
    PubMed    
    
    
    October 2023
25. AMPUERO J, Berzigotti A
    Prognostication in Advanced Chronic Liver Disease Using Liver Stiffness Measurement: Repetita Iuvant.
    Gastroenterology. 2023;165:829-831.
    PubMed    
    
    
    
26. SEMMLER G, Yang Z, Fritz L, Kock F, et al
    Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease.
    Gastroenterology. 2023;165:1041-1052.
    PubMed     Abstract available
    
    
    
27. MAN S, Deng Y, Ma Y, Fu J, et al
    Prevalence of Liver Steatosis and Fibrosis in the General Population and Various High-Risk Populations: A Nationwide Study With 5.7 Million Adults in China.
    Gastroenterology. 2023;165:1025-1040.
    PubMed     Abstract available
    
    
    
28. YIP TC, Fan JG, Wong VW
    China's Fatty Liver Crisis: A Looming Public Health Emergency.
    Gastroenterology. 2023;165:825-827.
    PubMed    
    
    
    
29. TICA S, Debosch BJ
    Bariatric Surgery for the Treatment of NASH-An Old Solution to a Newer Problem?
    Gastroenterology. 2023;165:1091.
    PubMed    
    
    
    
30. WATTACHERIL JJ, Abdelmalek MF, Lim JK, Sanyal AJ, et al
    AGA Clinical Practice Update on the Role of Noninvasive Biomarkers in the Evaluation and Management of Nonalcoholic Fatty Liver Disease: Expert Review.
    Gastroenterology. 2023;165:1080-1088.
    PubMed     Abstract available
    
    
    September 2023
31. CHEN J, Yang Q, Wang C
    Multiple Hepatic Masses in a Patient with Crohn's disease.
    Gastroenterology. 2023 Sep 20:S0016-5085(23)05014.
    PubMed    
    
    
    
32. XIE L, Guo H
    Question on the use of BMI >/= 25 kg/m(2) to define obesity to analyze the incidence and risk factors of hepatic steatosis and hepatic fibrosis in the Chinese population.
    Gastroenterology. 2023 Sep 8:S0016-5085(23)04983.
    PubMed    
    
    
    
33. MEZZACAPPA C
    Survival in unresectable hepatocellular carcinoma treated with a new immune checkpoint and anti-angiogenic drug combination.
    Gastroenterology. 2023 Sep 6:S0016-5085(23)04976.
    PubMed    
    
    
    
34. NEWMAN KL, Velez C, Paul S, Radix AE, et al
    Research Considerations in Digestive and Liver Disease in Transgender and Gender-Diverse Populations.
    Gastroenterology. 2023;165:523-528.
    PubMed    
    
    
    
35. WANG Y, Huang Y, Chase RC, Li T, et al
    Global Burden of Digestive Diseases: A Systematic Analysis of the Global Burden of Diseases Study, 1990 to 2019.
    Gastroenterology. 2023;165:773-783.
    PubMed     Abstract available
    
    
    
36. INTAGLIATA NM, Rahimi RS, Higuera-de-la-Tijera F, Simonetto DA, et al
    Procedural-Related Bleeding in Hospitalized Patients With Liver Disease (PROC-BLeeD): An International, Prospective, Multicenter Observational Study.
    Gastroenterology. 2023;165:717-732.
    PubMed     Abstract available
    
    
    
37. ZUO T, Xie Q, Liu J, Yang J, et al
    Macrophage-Derived Cathepsin S Remodels the Extracellular Matrix to Promote Liver Fibrogenesis.
    Gastroenterology. 2023;165:746-761.
    PubMed     Abstract available
    
    
    
38. FLIGOR SC, Tsikis ST, Hirsch TI, Pan A, et al
    A Medium-Chain Fatty Acid Analogue Prevents Intestinal Failure-Associated Liver Disease in Preterm Yorkshire Piglets.
    Gastroenterology. 2023;165:733-745.
    PubMed     Abstract available
    
    
    
39. WASSERMAN R, Reddy S, Grider D
    An Unusual Manifestation of Elevated Liver Enzymes and Architecture.
    Gastroenterology. 2023;165:e4-e6.
    PubMed    
    
    
    August 2023
40. HUANG DQ, Wilson LA, Behling C, Kleiner DE, et al
    Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study.
    Gastroenterology. 2023;165:463-472.
    PubMed     Abstract available
    
    
    
41. NAIMIMOHASSES S, Bhat M
    Genomic Analysis of Hair From Celebrated Composer Provides Insight Into Liver Disease Susceptibility.
    Gastroenterology. 2023;165:514.
    PubMed    
    
    
    
42. DEBOSCH BJ
    Next-Generation Farnesoid X Receptor Agonists in NASH Treatment: Are We There Yet?
    Gastroenterology. 2023;165:513-514.
    PubMed    
    
    
    
43. PENG Z, Li S, Pi R
    A Giant Cystic Liver Mass in an Elderly Man.
    Gastroenterology. 2023;165:e5-e7.
    PubMed    
    
    
    
44. ZHANG XF, Yin ZK, Zhang JY
    An Unusual Case of Intermittent Fever With Multiple Liver Lesions.
    Gastroenterology. 2023;165:e11-e14.
    PubMed    
    
    
    
45. KHAN AA, Turki M, Frandah W
    An Unusual Case of Hematemesis.
    Gastroenterology. 2023;165:e8-e10.
    PubMed    
    
    
    
46. SHEN C, Zhang J, Xia Q
    Unexpected Abdominal Wall Varices After Split-Liver Transplantation.
    Gastroenterology. 2023;165:354-356.
    PubMed    
    
    
    July 2023
47. REDDY KR, McLerran D, Marsh T, Parikh N, et al
    Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: the Multi-center Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study.
    Gastroenterology. 2023 Jul 8:S0016-5085(23)04765.
    PubMed     Abstract available
    
    
    
48. LO YN, Wu JS, Chiang HC
    A Pseudo-Gastric Bubble.
    Gastroenterology. 2023;165:e16-e18.
    PubMed    
    
    
    
49. LI GF, Yu G
    Drug-induced Liver Injury With Ritonavir-Boosted Nirmatrelvir: Evidence From Coronavirus Disease 2019 Emergency Use Authorization Adverse Event Reporting System.
    Gastroenterology. 2023;165:305-306.
    PubMed    
    
    
    
50. DEBOSCH B
    Obeying the Law: Energy Balance in Alternate-Day Fasting, Exercise, or Both Together in Patients With Obesity and NAFLD.
    Gastroenterology. 2023;165:301.
    PubMed    
    
    
    
51. RATZIU V, Friedman SL
    Why Do So Many Nonalcoholic Steatohepatitis Trials Fail?
    Gastroenterology. 2023;165:5-10.
    PubMed    
    
    
    June 2023
52. NISHIWAKI T, Tsutsumi Y, Nakaji S
    A mysterious hepatic mass.
    Gastroenterology. 2023 Jun 15:S0016-5085(23)00879.
    PubMed    
    
    
    
53. CHINNASAMY V, Sakulsaengprapha V, Mathews SC
    The Benefit of Artificial Intelligence-Based Diagnosis in Gastroenterology and Hepatology is Highly Variable: A Diagnostic Need and Burden Analysis.
    Gastroenterology. 2023 Jun 2:S0016-5085(23)00818.
    PubMed    
    
    
    
54. THIELE M, Suvitaival T, Trost K, Kim M, et al
    Sphingolipids Are Depleted in Alcohol-Related Liver Fibrosis.
    Gastroenterology. 2023;164:1248-1260.
    PubMed     Abstract available
    
    
    
55. SCHEINER B, Pinato DJ
    Tumor-infiltrating Neutrophils: Gatekeepers in Liver Cancer Immune Control.
    Gastroenterology. 2023;164:1338-1339.
    PubMed    
    
    
    
56. MULLISH BH
    The Impact of Proportional Dietary Carbohydrate and Fat Content on Type 2 Diabetes and NAFLD.
    Gastroenterology. 2023;164:1338.
    PubMed    
    
    
    
57. LIU W, Wei DH, Tong QY
    The Bull's-Eye Sign in Liver: Are They Liver Metastases?
    Gastroenterology. 2023;164:1056-1058.
    PubMed    
    
    
    May 2023
58. FARIAS AQ, Vilalta AC, Zitelli PM, Pereira G, et al
    Genetic Ancestry, Race, and Severity of Acutely Decompensated Cirrhosis in Latin America.
    Gastroenterology. 2023 May 30:S0016-5085(23)00806.
    PubMed     Abstract available
    
    
    
59. YANG XM, Wang XQ, Hu LP, Feng MX, et al
    Nucleolar HEATR1 upregulated by mTORC1 signaling promotes hepatocellular carcinoma growth by dominating ribosome biogenesis and proteome homeostasis.
    Gastroenterology. 2023 May 27:S0016-5085(23)00802.
    PubMed     Abstract available
    
    
    
60. WANG J, Yu H, Dong W, Zhang C, et al
    N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells' Properties and Lenvatinib Resistance Through WNT/beta-Catenin and Hippo Signaling Pathways.
    Gastroenterology. 2023;164:990-1005.
    PubMed     Abstract available
    
    
    April 2023
61. CHO MY, Sung PS, Lee SH
    Multiple Hepatic Artery Pseudoaneurysms with Eosinophilia.
    Gastroenterology. 2023 Apr 26:S0016-5085(23)00629.
    PubMed    
    
    
    
62. HAN H, Ge X, Babu Komakula SS, Desert R, et al
    MACROPHAGE-DERIVED OSTEOPONTIN (SPP1) PROTECTS FROM NON-ALCOHOLIC STEATOHEPATITIS.
    Gastroenterology. 2023 Apr 5:S0016-5085(23)00581.
    PubMed     Abstract available
    
    
    
63. GOLDOWSKY A, Ding J, Velez C, Paul S, et al
    Improving the Experiences of Sexual and Gender Minority-Identifying Trainees in Gastroenterology and Hepatology.
    Gastroenterology. 2023;164:510-514.
    PubMed    
    
    
    
64. XU X, Alanaeme J, Wen Y, Colantonio LD, et al
    Real-World Implications of the American Gastroenterology Association Nonalcoholic Fatty Liver Disease Clinical Care Pathway in the US Adult Population.
    Gastroenterology. 2023;164:688-689.
    PubMed    
    
    
    
65. GADIYARAM S, Nachiappan M
    An Unusual Cause of Lower Gastrointestinal Bleeding.
    Gastroenterology. 2023;164:e4-e7.
    PubMed    
    
    
    March 2023
66. EINER C, Munk DE, Park E, Akdogan B, et al
    ARBM101 (Methanobactin SB2) drains excess liver copper via biliary excretion in Wilson Disease rats.
    Gastroenterology. 2023 Mar 24:S0016-5085(23)00529.
    PubMed     Abstract available
    
    
    
67. GADIYARAM S, Nachiappan M, Kini D
    Liver SOL in a case of colon cancer, a red herring.
    Gastroenterology. 2023 Mar 24:S0016-5085(23)00534.
    PubMed    
    
    
    
68. KO PH, Tseng CW
    An Unusual Cause of Acute Cholecystitis.
    Gastroenterology. 2023 Mar 23:S0016-5085(23)00531.
    PubMed    
    
    
    
69. KUCUKKOSE E, Laoukili J, Gorelick AN, Degner S, et al
    Lymphatic invasion of plakoglobin-dependent tumor cell clusters drives formation of polyclonal lung metastases in colon cancer.
    Gastroenterology. 2023 Mar 9:S0016-5085(23)00256.
    PubMed     Abstract available
    
    
    
70. SAITO Y, Yin D, Kubota N, Wang X, et al
    A therapeutically targetable TAZ-TEAD2 pathway drives the growth of hepatocellular carcinoma via ANLN and KIF23.
    Gastroenterology. 2023 Mar 7:S0016-5085(23)00235.
    PubMed     Abstract available
    
    
    
71. ESPINOZA M, Muiquith M, Lim M, Zhu H, et al
    Disease etiology and outcomes after atezolizumab plus bevacizumab in hepatocellular carcinoma: Post-hoc analysis of IMbrave150.
    Gastroenterology. 2023 Mar 7:S0016-5085(23)00234.
    PubMed    
    
    
    
72. YANG S, Qian L, Li Z, Li Y, et al
    Integrated Multi-Omics Landscape of Liver Metastases.
    Gastroenterology. 2023;164:407-423.
    PubMed     Abstract available
    
    
    
73. NICOLETTI P, Dellinger A, Li YJ, Barnhart HX, et al
    Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate.
    Gastroenterology. 2023;164:454-466.
    PubMed     Abstract available
    
    
    
74. SUN J, Debosch B
    Guardian, Intermediary, or Perpetrator? New Insights Into Environmental Exposure, the Gut Microbiome, and Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2023;164:492.
    PubMed    
    
    
    
75. SHA M, Tong Y, Cao J
    "Malignant" Liver Lesions in an Incidental But High-Risk Patient.
    Gastroenterology. 2023;164:e17-e19.
    PubMed    
    
    
    
76. LIU R, Dai Z, Zhu C
    A Rare Cause of Liver Fibrosis in an Adolescent Woman.
    Gastroenterology. 2023;164:340-343.
    PubMed    
    
    
    
77. NADOLSKY KZ
    Use of the Term "Lean" for Nonalcoholic Fatty Liver Disease in Individuals With Low Body Mass Index.
    Gastroenterology. 2023;164:502-503.
    PubMed    
    
    
    
78. TAMBAKIS G, Florescu C, Tsoi E
    Three Lumens Full of Blood-An Unusual Case of Gastrointestinal Bleeding.
    Gastroenterology. 2023;164:334-335.
    PubMed    
    
    
    February 2023
79. L'HERMITE S, Bordet M, Rayer C
    A Woman With Recurrent Upper Gastrointestinal Bleeding.
    Gastroenterology. 2023 Feb 18:S0016-5085(23)00152.
    PubMed    
    
    
    
80. ZHOU C, Weng J, Liu C, Liu S, et al
    Disruption of SLFN11 deficiency-induced CCL2 signaling and macrophage M2 polarization potentiates anti-PD-1 therapy efficacy in hepatocellular carcinoma.
    Gastroenterology. 2023 Feb 14:S0016-5085(23)00137.
    PubMed     Abstract available
    
    
    
81. CHEN VL, Oliveri A, Miller MJ, Wijarnpreecha K, et al
    PNPLA3 genotype and diabetes identify patients with non-alcoholic fatty liver disease at high risk of incident cirrhosis.
    Gastroenterology. 2023 Feb 7:S0016-5085(23)00113.
    PubMed     Abstract available
    
    
    
82. TOH MR, Wong Yi Ting E, Wong Hei S, Ng Wei Tian A, et al
    Global epidemiology and genetics of hepatocellular carcinoma.
    Gastroenterology. 2023 Feb 2:S0016-5085(23)00105.
    PubMed     Abstract available
    
    
    
83. UFERE NN, El-Jawahri A, Ritchie C, Lai JC, et al
    Promoting Prognostic Understanding and Health Equity for Patients With Advanced Liver Disease: Using "Best Case/Worst Case".
    Gastroenterology. 2023;164:171-176.
    PubMed    
    
    
    
84. PATEL AA, Arnold RM, Taddei TH, Woodrell CD, et al
    "Am I Going to Die?": Delivering Serious News to Patients With Liver Disease.
    Gastroenterology. 2023;164:177-181.
    PubMed    
    
    
    
85. DEBOSCH BJ
    A deCIDEdly New Germline Mutation That Protects Against Liver Disease.
    Gastroenterology. 2023;164:304-305.
    PubMed    
    
    
    
86. ZHU Y, Li X, He S
    Identification and Treatment of an Unusual Cause of Gastrointestinal Bleeding.
    Gastroenterology. 2023;164:e17-e20.
    PubMed    
    
    
    January 2023
87. XIAO X, Yao D, Yang J
    An uncommon upper gastrointestinal bleeding.
    Gastroenterology. 2023 Jan 27:S0016-5085(23)00052.
    PubMed    
    
    
    
88. LIM M, Franses JW, Imperial R, Majeed U, et al
    EGFR/ERBB2 amplifications and alterations associated with resistance to lenvatinib in hepatocellular carcinoma.
    Gastroenterology. 2023 Jan 25:S0016-5085(23)00056.
    PubMed    
    
    
    
89. WANG B, Bonkovsky HL, Lim JK, Balwani M, et al
    AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review.
    Gastroenterology. 2023 Jan 13:S0016-5085(22)01356.
    PubMed     Abstract available
    
    
    
90. WONG GL, Hui VW, Yip TC, Lui GC, et al
    Minimal Risk of Drug-Induced Liver Injury With Molnupiravir and Ritonavir-Boosted Nirmatrelvir.
    Gastroenterology. 2023;164:151-153.
    PubMed    
    
    
    
91. MITZLAFF K, Sayk F, Solbach P
    Jaundice and Weight Gain After Autologous Stem Cell Transplantation in a 28-Year-Old Patient With Diffuse Large B-Cell Lymphoma.
    Gastroenterology. 2023;164:32-33.
    PubMed    
    
    
    
92. SALIM Z, Laycock A, Hewavitharana C
    Abdominal Pain After Transarterial Chemoembolization.
    Gastroenterology. 2023;164:27-29.
    PubMed    
    
    
    December 2022
93. MO TT, Li M, Wang XY
    An Unusual Cause of Portal Hypertension.
    Gastroenterology. 2022 Dec 30:S0016-5085(22)01453.
    PubMed    
    
    
    
94. BLOCK PD, Farrell JJ, Li DK
    A Rare Cause of Gastrointestinal Bleeding after Pancreaticoduodenectomy.
    Gastroenterology. 2022 Dec 30:S0016-5085(22)01449.
    PubMed    
    
    
    
95. YEOH BS, Saha P, Golonka RM, Zou J, et al
    Enterohepatic Shunt-Driven Cholemia Predisposes to Liver Cancer.
    Gastroenterology. 2022;163:1658-1671.
    PubMed     Abstract available
    
    
    
96. ZHU Y, Shi H, He S
    An Unusual Cause of Gastric Variceal Bleeding.
    Gastroenterology. 2022;163:1502-1504.
    PubMed    
    
    
    
97. ROBBINS J, El Hassan I, Siebenburgen C
    Evaluation and Treatment of GI Bleeding in a 51-Year-Old Man.
    Gastroenterology. 2022;163:1498-1501.
    PubMed    
    
    
    November 2022
98. OH AR, Jeong Y, Yu J, Minh Tam DT, et al
    Hepatocyte Kctd17 inhibition ameliorates glucose intolerance and hepatic steatosis caused by obesity-induced Chrebp stabilization.
    Gastroenterology. 2022 Nov 16:S0016-5085(22)01295.
    PubMed     Abstract available
    
    
    
99. ZHANG H, Peng Y, Tang X
    Comments on "Diversity, Equity, and Inclusion in Gastroenterology and Hepatology: A Survey of Where We Stand".
    Gastroenterology. 2022 Nov 14. pii: S0016-5085(22)01271.
    PubMed    
    
    
    
100. WANG Z, Tai Y, Wu H
     A rare cause of abdominal pain after transjugular intrahepatic portosystemic shunt.
     Gastroenterology. 2022 Nov 10. pii: S0016-5085(22)01258.
     PubMed    
     
     
     
101. BRANDI G, Tovoli F, Tavolari S
     Have We Found the "Holy Grail" That May Predict Response to Immunotherapy in Hepatocellular Carcinoma?
     Gastroenterology. 2022 Nov 4. pii: S0016-5085(22)01252.
     PubMed    
     
     
     
102. PRASOPPOKAKORN T, Rerknimitr R
     An Unusual Complication of Endoscopic Cyanoacrylate Injection for Gastric Varix.
     Gastroenterology. 2022;163:1186-1187.
     PubMed    
     
     
     
103. MAGAHIS P, Rosenblatt R, Mahadev S
     An Unusual Cause of Right Upper Quadrant Pain With Abnormal Liver Enzymes.
     Gastroenterology. 2022;163:e3-e5.
     PubMed    
     
     
     October 2022
104. RAHAL HK, Tabibian JH, Issaka RB, Quezada S, et al
     Diversity, Equity, and Inclusion in Gastroenterology and Hepatology: A Survey of Where We Stand.
     Gastroenterology. 2022 Oct 7. pii: S0016-5085(22)00721.
     PubMed     Abstract available
     
     
     
105. BEHARI J
     Needle-free Nonalcoholic Fatty Liver Disease Prognostication: Moving One Step Closer.
     Gastroenterology. 2022;163:819-822.
     PubMed    
     
     
     
106. AJMERA V, Kim BK, Yang K, Majzoub AM, et al
     Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants.
     Gastroenterology. 2022;163:1079-1089.
     PubMed     Abstract available
     
     
     
107. SHINGINA A, Sarkar M, Feld L
     On the Importance of Safe Access to Reproductive Options for Adolescents and Women With Liver Disease.
     Gastroenterology. 2022;163:792-794.
     PubMed    
     
     
     
108. BAJAJ JS, Nagy LE
     Natural History of Alcohol-Associated Liver Disease: Understanding the Changing Landscape of Pathophysiology and Patient Care.
     Gastroenterology. 2022;163:840-851.
     PubMed     Abstract available
     
     
     September 2022
109. LI H, Zheng J, Xu Q, Yang Y, et al
     Hepatocyte Adenosine Kinase Promotes Excessive Fat Deposition and Liver Inflammation.
     Gastroenterology. 2022 Sep 28. pii: S0016-5085(22)01085.
     PubMed     Abstract available
     
     
     
110. DARA L
     No Necroptosis in Hepatocytes: The Final Nail in the Coffin?
     Gastroenterology. 2022 Sep 22. pii: S0016-5085(22)01083.
     PubMed    
     
     
     
111. MURILLO PEREZ CF, Fisher H, Hiu S, Kareithi D, et al
     Greater Transplant-free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls.
     Gastroenterology. 2022 Sep 13. pii: S0016-5085(22)01060.
     PubMed     Abstract available
     
     
     
112. HABER PK, Castet F, Torres-Martin M, Andreu-Oller C, et al
     Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma.
     Gastroenterology. 2022 Sep 12. pii: S0016-5085(22)01039.
     PubMed     Abstract available
     
     
     
113. LONG MT, Noureddin M, Lim JK
     AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review.
     Gastroenterology. 2022;163:764-774.
     PubMed     Abstract available
     
     
     
114. LEE BP, Terrault NA
     Advocacy for Equity in Transplantation Access for Alcohol-Associated Liver Disease: How Research Changed Medi-Cal Policy.
     Gastroenterology. 2022;163:539-542.
     PubMed    
     
     
     August 2022
115. PRESTON SP, Stutz MD, Allison CC, Nachbur U, et al
     Epigenetic silencing of RIPK3 in hepatocytes prevents MLKL-mediated necroptosis from contributing to liver pathologies.
     Gastroenterology. 2022 Aug 26. pii: S0016-5085(22)01021.
     PubMed     Abstract available
     
     
     
116. LIU J, Feng G
     A 41-year-old man with an abdominal mass and hepatomegaly.
     Gastroenterology. 2022 Aug 17. pii: S0016-5085(22)00957.
     PubMed    
     
     
     
117. D'ALESSIO A, Pinato DJ
     Dissecting the tumour microenvironment to predict immunotherapy response in hepatocellular cancer.
     Gastroenterology. 2022 Aug 11. pii: S0016-5085(22)00950.
     PubMed    
     
     
     
118. DEBOSCH B
     Targeting de novo lipogenesis by different approaches shows promise in non-alcoholic steatohepatitis.
     Gastroenterology. 2022 Aug 10. pii: S0016-5085(22)00915.
     PubMed    
     
     
     
119. CLIFFORD C, Ryan R, Houlihan D
     An interesting case of hepatomegaly.
     Gastroenterology. 2022 Aug 10. pii: S0016-5085(22)00945.
     PubMed    
     
     
     
120. LO GH
     The beauty and sorrow of using PPI in patients with cirrhosis.
     Gastroenterology. 2022 Aug 3. pii: S0016-5085(22)00892.
     PubMed    
     
     
     
121. MULLISH BH
     Further Insights Into the Impact of Bariatric Surgery on the Progression of Nonalcoholic Fatty Liver Disease.
     Gastroenterology. 2022;163:528-529.
     PubMed    
     
     
     
122. LE COSQUER G, Brunac AC, Peron JM
     An Unusual Case of Budd-Chiari Syndrome: Diagnosis and Treatment.
     Gastroenterology. 2022;163:e4-e5.
     PubMed    
     
     
     July 2022
123. BENHAMMOU JN, Rich NE, Cholankeril G, Zhang P, et al
     DETECT: Development of Technologies for Early HCC Detection.
     Gastroenterology. 2022;163:21-27.
     PubMed    
     
     
     
124. JAN J, Osho A, Murphy CC, Mazure CM, et al
     Gender, Age, Racial and Ethnic Disparities in Clinical Trial Enrollment for Primary Liver Cancer.
     Gastroenterology. 2022;163:14-20.
     PubMed    
     
     
     
125. TERRAULT NA, Williamson C
     Pregnancy-Associated Liver Diseases.
     Gastroenterology. 2022;163:97-117.
     PubMed     Abstract available
     
     
     
126. KARACHALIOU GS, Shi C, Abdelmalek MF
     Liver Mass: Thinking Out of the Box.
     Gastroenterology. 2022;163:e10-e12.
     PubMed    
     
     
     June 2022
127. KIM NJ, Vutien P, Berry K, Ioannou GN, et al
     Hepatocellular carcinoma risk declines but remains high enough for screening in the first 7 years after HCV cure with DAAs in patients with cirrhosis or high FIB-4.
     Gastroenterology. 2022 Jun 28. pii: S0016-5085(22)00681.
     PubMed    
     
     
     
128. BLAIR AB, Wang J, Davelaar J, Baker A, et al
     Dual stromal targeting sensitizes pancreatic adenocarcinoma for anti-PD-1 therapy.
     Gastroenterology. 2022 Jun 16. pii: S0016-5085(22)00645.
     PubMed     Abstract available
     
     
     
129. YING X, Rosenblatt R, Fortune BE
     Trends in Industry Payments to Gastroenterologists and Hepatologists in the United States from 2014 to 2020.
     Gastroenterology. 2022 Jun 14. pii: S0016-5085(22)00647.
     PubMed    
     
     
     
130. DUURSMA SS, Verkade HJ, Bodewes FAJA
     Cirrhosis and portal hypertension in compound heterozygous people with CF harboring one F508del CFTR gene mutation.
     Gastroenterology. 2022 Jun 10. pii: S0016-5085(22)00624.
     PubMed    
     
     
     
131. BAUER KC, Littlejohn PT, Ayala V, Creus-Cuadros A, et al
     Nonalcoholic Fatty Liver Disease and the Gut-Liver Axis: Exploring an Undernutrition Perspective.
     Gastroenterology. 2022;162:1858-1875.
     PubMed     Abstract available
     
     
     
132. SULLIVAN S, Jirapinyo P, Kumbhari V
     Clinical Care Pathway for the Risk Stratification and Management of Patients With Non-alcoholic Fatty Liver Disease.
     Gastroenterology. 2022;162:2131-2132.
     PubMed    
     
     
     May 2022
133. WANG J, Liu D, Chen S
     Proton Pump Inhibitors for Patients with Cirrhosis: Good Medicine or Poison?
     Gastroenterology. 2022 May 17. pii: S0016-5085(22)00514.
     PubMed    
     
     
     
134. NATSUI K, Maruyama M, Terai S
     Intrahepatic bile duct foreign body with cholangitis after pylorus preserving pancreatoduodenectomy: Is it a fish bone?
     Gastroenterology. 2022 May 14. pii: S0016-5085(22)00507.
     PubMed    
     
     
     
135. HU S, Molina L, Tao J, Liu S, et al
     NOTCH-YAP1/TEAD-DNMT1 axis drives hepatocyte reprogramming into intrahepatic cholangiocarcinoma.
     Gastroenterology. 2022 May 9. pii: S0016-5085(22)00477.
     PubMed     Abstract available
     
     
     
136. SINGH SP
     Proton pump inhibitor increasing the risk of infection and mortality in cirrhosis- need closer look!
     Gastroenterology. 2022 May 2. pii: S0016-5085(22)00458.
     PubMed    
     
     
     
137. DONNELLY MC, Stableforth W, Krag A, Reuben A, et al
     The Negative Bidirectional Interaction Between Climate Change and the Prevalence and Care of Liver Disease: A Joint BSG, BASL, EASL, and AASLD Commentary.
     Gastroenterology. 2022;162:1561-1567.
     PubMed    
     
     
     
138. GOUDSMIT BFJ, Putter H, Van Hoek B
     The Model for End-Stage Liver Disease 3.0: An Update Without Proven Accuracy.
     Gastroenterology. 2022;162:1781-1782.
     PubMed    
     
     
     
139. GAN W, Liao B, Li X
     A Rare Cause of Liver Fibrosis in Adulthood.
     Gastroenterology. 2022;162:e1-e3.
     PubMed    
     
     
     April 2022
140. CACCIOLA I
     Effects of PPIs in cirrhotic patients: What do we really know?
     Gastroenterology. 2022 Apr 29. pii: S0016-5085(22)00452.
     PubMed    
     
     
     
141. COPPS KD, Tao R
     A role for hepatic insulin signaling in alpha1-antitrypsin deficiency.
     Gastroenterology. 2022 Apr 29. pii: S0016-5085(22)00457.
     PubMed    
     
     
     
142. MAHMUD N, Serper M, Taddei TH, Kaplan DE, et al
     The Association between Proton Pump Inhibitor Exposure and Key Liver-Related Outcomes in Patients with Cirrhosis: A Veterans Affairs Cohort Study.
     Gastroenterology. 2022 Apr 6. pii: S0016-5085(22)00352.
     PubMed     Abstract available
     
     
     
143. YANG Y, Ju C
     Sulfation in Acetaminophen-Induced Liver Injury: Friend or Foe?
     Gastroenterology. 2022;162:1035-1037.
     PubMed    
     
     
     
144. XU P, Xi Y, Wang P, Luka Z, et al
     Inhibition of p53 Sulfoconjugation Prevents Oxidative Hepatotoxicity and Acute Liver Failure.
     Gastroenterology. 2022;162:1226-1241.
     PubMed     Abstract available
     
     
     
145. QIAN T, Fujiwara N, Koneru B, Ono A, et al
     Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development.
     Gastroenterology. 2022;162:1210-1225.
     PubMed     Abstract available
     
     
     March 2022
146. RUDNICK DA, Huang J, Hidvegi T, Chu AS, et al
     Regulation of PGC1alpha downstream of the insulin signaling pathway plays a role in the hepatic proteotoxicity of mutant alpha1-antitrypsin deficiency variant Z.
     Gastroenterology. 2022 Mar 14. pii: S0016-5085(22)00261.
     PubMed     Abstract available
     
     
     
147. VELENOSI TJ, Ben-Yakov G, Podszun MC, Hercun J, et al
     Postprandial plasma lipidomics reveal specific alteration of hepatic-derived diacylglycerols in non-alcoholic fatty liver disease.
     Gastroenterology. 2022 Mar 10. pii: S0016-5085(22)00235.
     PubMed     Abstract available
     
     
     
148. ALTAYAR O, Shah R, Chang CY, Falck-Ytter Y, et al
     AGA Technical Review on Systemic Therapies for Hepatocellular Carcinoma.
     Gastroenterology. 2022;162:937-951.
     PubMed    
     
     
     
149. SU GL, Altayar O, O'Shea R, Shah R, et al
     AGA Clinical Practice Guideline on Systemic Therapy for Hepatocellular Carcinoma.
     Gastroenterology. 2022;162:920-934.
     PubMed     Abstract available
     
     
     
150. MAYDEO A, Patil G
     How to Approach a Patient With Gastric Varices.
     Gastroenterology. 2022;162:689-695.
     PubMed    
     
     
     February 2022
151. CHENG N, Ren Y, Zhou J, Zhang Y, et al
     Deep learning-based classification of hepatocellular nodular lesions on whole-slide histopathologic images.
     Gastroenterology. 2022 Feb 21. pii: S0016-5085(22)00155.
     PubMed     Abstract available
     
     
     
152. CARRIQUE L, Lynch J, Selzner N
     We thank Bekki et al and Bhagat et al for their comments on our article "Results of Early Transplantation for Alcohol-Related Cirrhosis: Integrated Addiction Treatment with Low Rate of Relapse". Bekki et al pointed out a trend toward inferior graft su
     Gastroenterology. 2022 Feb 3. pii: S0016-5085(22)00103.
     PubMed    
     
     
     
153. STRAZZABOSCO M, Cabibbo G, Colombo M
     Adjusting BCLC staging system to the evolving landscape of Hepatocellular Carcinoma. A look to the future.
     Gastroenterology. 2022 Feb 2. pii: S0016-5085(22)00090.
     PubMed    
     
     
     
154. KANNEGANTI M, Singal AG
     INCIDENCE OF HEPATOCELLULAR CARCINOMA IN NONALCOHOLIC FATTY LIVER DISEASE.
     Gastroenterology. 2022 Feb 1. pii: S0016-5085(22)00092.
     PubMed     Abstract available
     
     
     
155. LEE SK, Wong JC, Ng JJ
     An Uncommon Cause of Hematemesis in a Patient With End-stage Renal Disease.
     Gastroenterology. 2022;162:404-405.
     PubMed    
     
     
     
156. TAI Y, Wang Z, Wu H
     An Unusual Cause of Isolated Gastric Varices.
     Gastroenterology. 2022;162:e4-e6.
     PubMed    
     
     
     
157. QU C, Wang HY, Xiu DR
     A Rare Liver Tumor Nodule.
     Gastroenterology. 2022;162:e1-e3.
     PubMed    
     
     
     January 2022
158. WILLIAMS R, White PM, Balzora S
     "A T.E.A.M. Approach to Diversity, Equity and Inclusion in Gastroenterology and Hepatology".
     Gastroenterology. 2022 Jan 21. pii: S0016-5085(22)00035.
     PubMed    
     
     
     
159. WILSON SR, Duncan AW
     Single-Cell DNA Sequencing Reveals Chromosomal Diversity in HCC and a Novel Model of HCC Evolution.
     Gastroenterology. 2022;162:46-48.
     PubMed    
     
     
     December 2021
160. YANG AH, Gandhi S, Urrunaga NH
     Liver Tumor post Liver Transplantation for Hepatitis C Cirrhosis: An Unusual Cause.
     Gastroenterology. 2021 Dec 26. pii: S0016-5085(21)04161.
     PubMed    
     
     
     
161. FORNER A, Colombo M
     The maze of systemic therapy for hepatocellular carcinoma: did we find the compass?
     Gastroenterology. 2021 Dec 23. pii: S0016-5085(21)04121.
     PubMed    
     
     
     
162. KEFALAKES H
     DISPARITIES IN CIRRHOSIS MANAGEMENT OF BLACK PATIENTS: DO WE KNOW WHAT TO ADDRESS?
     Gastroenterology. 2021 Dec 1. pii: S0016-5085(21)03811.
     PubMed    
     
     
     
163. GERMAN MN, Brown R, Lucey MR
     Out With the Old, in With the New: Replacing the "6-Month Abstinence Rule" With Integrated Care for Alcohol-Associated Liver Disease.
     Gastroenterology. 2021;161:1795-1797.
     PubMed    
     
     
     
164. POLLO-FLORES P, Trebicka J
     Statins After Variceal Bleeding Are Beneficial, but Still an Unexplained Mystery?
     Gastroenterology. 2021;161:2067-2068.
     PubMed    
     
     
     
165. BARRITT AS 4TH, Moon AM
     Bariatric Surgery and Cancer Risk in Nonalcoholic Fatty Liver Disease-Effective Intervention for a Select Few.
     Gastroenterology. 2021;161:2063-2064.
     PubMed    
     
     
     
166. RAMAI D, Facciorusso A
     Liver Cancer Reduction After Bariatric Surgery: Time to Expand Its Indication?
     Gastroenterology. 2021;161:2063.
     PubMed    
     
     
     
167. KIM WR, Mannalithara A, Heimbach JK, Kamath PS, et al
     MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.
     Gastroenterology. 2021;161:1887-1895.
     PubMed     Abstract available
     
     
     
168. SACK JS, Patel RS, Ahmad J
     Nausea and Vomiting 8 Months After Liver Transplantation.
     Gastroenterology. 2021;161:e12-e14.
     PubMed    
     
     
     November 2021
169. LOOMBA R, Ratziu V, Harrison SA
     Expert Panel Review to Compare FDA and EMA Guidance on Drug Development and Endpoints in Nonalcoholic Steatohepatitis.
     Gastroenterology. 2021 Nov 22. pii: S0016-5085(21)03795.
     PubMed    
     
     
     
170. BHAGAT N, Rathi S, Singh V
     Early Transplantation for Alcohol-Related Cirrhosis: Risks, Resources, and Relapse.
     Gastroenterology. 2021 Nov 5. pii: S0016-5085(21)03724.
     PubMed    
     
     
     
171. KANWAL F, Shubrook JH, Adams LA, Pfotenhauer K, et al
     Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease.
     Gastroenterology. 2021;161:1657-1669.
     PubMed     Abstract available
     
     
     
172. WANG X, Cheng Z
     Nodules on the Lower Legs With Ankle Joint Pain.
     Gastroenterology. 2021;161:1390-1392.
     PubMed    
     
     
     
173. VARGAS JF, Arab JP
     Pulsatile Epigastric Mass and Liver Masses in a 38-Year-Old Patient With Splenomegaly Since Childhood.
     Gastroenterology. 2021;161:e14-e16.
     PubMed    
     
     
     October 2021
174. LEE TH, Roper J, King L
     MIRROR MIRROR ON THE WALL, WHO IS THE FITTEST OF THEM ALL: A NOVEL PREDICTION MODEL FOR POSTOPERATIVE HEPATIC DECOMPENSATION IN PATIENTS WITH CIRRHOSIS.
     Gastroenterology. 2021 Oct 21. pii: S0016-5085(21)03662.
     PubMed     Abstract available
     
     
     
175. LIU N, Chang CW, Steer CJ, Wang XW, et al
     MicroRNA-15a/16-1 Prevents Hepatocellular Carcinoma by Disrupting the Communication between Kupffer Cells and Tregs.
     Gastroenterology. 2021 Oct 19. pii: S0016-5085(21)03652.
     PubMed     Abstract available
     
     
     
176. PEERY AF, Crockett SD, Murphy CC, Jensen ET, et al
     Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021.
     Gastroenterology. 2021 Oct 19. pii: S0016-5085(21)03655.
     PubMed     Abstract available
     
     
     
177. LOUISSAINT J, Gibbs JT, Lok AS, Tapper EB, et al
     Strategies to Improve Video Visit Use in Persons With Liver Disease.
     Gastroenterology. 2021;161:1080-1084.
     PubMed    
     
     
     September 2021
178. INTAGLIATA NM, Davitkov P, Allen AM, Falck-Ytter YT, et al
     AGA Technical Review on Coagulation in Cirrhosis.
     Gastroenterology. 2021 Sep 24. pii: S0016-5085(21)03477.
     PubMed    
     
     
     
179. O'SHEA RS, Davitkov P, Ko CW, Rajasekhar A, et al
     AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis.
     Gastroenterology. 2021 Sep 24. pii: S0016-5085(21)03382.
     PubMed    
     
     
     
180. DREYER SB, Upstill-Goddard R, Legrini A, Biankin AV, et al
     Genomic and molecular analyses identify molecular subtypes of pancreatic cancer recurrence.
     Gastroenterology. 2021 Sep 14. pii: S0016-5085(21)03522.
     PubMed    
     
     
     
181. BEKKI Y, Fenig Y
     Evaluation of Early Liver Transplantation for Alcohol-Related Cirrhosis.
     Gastroenterology. 2021 Sep 13. pii: S0016-5085(21)03491.
     PubMed    
     
     
     
182. SHAH BJ, Onken JE, Edgar L, Jou JH, et al
     Development of Gastroenterology and Transplant Hepatology Milestones 2.0: A Guide for Programs, Faculty, and Fellows.
     Gastroenterology. 2021 Sep 3. pii: S0016-5085(21)03335.
     PubMed    
     
     
     
183. GUO L, Yi X, Chen L, Zhang T, et al
     Single cell DNA sequencing reveals punctuated and gradual clonal evolution in hepatocellular carcinoma.
     Gastroenterology. 2021 Sep 2. pii: S0016-5085(21)03471.
     PubMed     Abstract available
     
     
     
184. KANWAL F, Shubrook JH, Younossi Z, Natarajan Y, et al
     Preparing for the NASH Epidemic: A Call to Action.
     Gastroenterology. 2021;161:1030-1042.
     PubMed     Abstract available
     
     
     
185. HABER PK, Puigvehi M, Castet F, Lourdusamy V, et al
     Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002-2020).
     Gastroenterology. 2021;161:879-898.
     PubMed     Abstract available
     
     
     
186. DE BUCOURT M
     A Visual Engram Worth Remembering.
     Gastroenterology. 2021;161:809-810.
     PubMed    
     
     
     
187. FUCHS A, Samovski D, Smith GI, Cifarelli V, et al
     Associations Among Adipose Tissue Immunology, Inflammation, Exosomes and Insulin Sensitivity in People With Obesity and Nonalcoholic Fatty Liver Disease.
     Gastroenterology. 2021;161:968-981.
     PubMed     Abstract available
     
     
     August 2021
188. BALZORA S, May FP, Ogedegbe G
     COVID-19 and Social Determinants of Health in Gastroenterology and Hepatology.
     Gastroenterology. 2021 Aug 26. pii: S0016-5085(21)03438.
     PubMed    
     
     
     
189. SU F
     COVID-19 and cirrhosis: a combination we must strive to prevent.
     Gastroenterology. 2021 Aug 25. pii: S0016-5085(21)03417.
     PubMed    
     
     
     
190. AZZIMATO V, Chen P, Barreby E, Morgantini C, et al
     Hepatic miR-144 drives fumarase activity preventing NRF2 activation during obesity.
     Gastroenterology. 2021 Aug 20. pii: S0016-5085(21)03410.
     PubMed     Abstract available
     
     
     
191. OLYNYK JK, Ramm GA
     RISK OF LIVER CANCER IN HFE-HEMOCHROMATOSIS.
     Gastroenterology. 2021 Aug 19. pii: S0016-5085(21)03405.
     PubMed     Abstract available
     
     
     
192. TAI CS, Ni YH, Lee PI
     An Unusual Case with a Huge Hepatic Cystic Mass.
     Gastroenterology. 2021 Aug 12. pii: S0016-5085(21)03357.
     PubMed    
     
     
     
193. CARRIQUE L, Quance J, Tan A, Abbey S, et al
     Results of Early Transplantation for Alcohol-Related Cirrhosis: Integrated Addiction Treatment with Low Rate of Relapse.
     Gastroenterology. 2021 Aug 6. pii: S0016-5085(21)03342.
     PubMed     Abstract available
     
     
     
194. GOUGH NR, Xiang X, Mishra L
     TGF-beta Signaling in Liver, Pancreas, and Gastrointestinal Diseases and Cancer.
     Gastroenterology. 2021;161:434-452.
     PubMed     Abstract available
     
     
     July 2021
195. MEHTA N, Frenette C, Tabrizian P, Hoteit M, et al
     Down-staging Outcomes for Hepatocellular Carcinoma: Results from the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium.
     Gastroenterology. 2021 Jul 28. pii: S0016-5085(21)03284.
     PubMed     Abstract available
     
     
     
196. LOOMBA R, Mohseni R, Lucas KJ, Gutierrez JA, et al
     TVB-2640 (FASN inhibitor) for the treatment of nonalcoholic steatohepatitis: FASCINATE-1, a randomized, placebo-controlled Ph2a trial.
     Gastroenterology. 2021 Jul 20. pii: S0016-5085(21)03276.
     PubMed     Abstract available
     
     
     
197. GE J, Pletcher MJ, Lai JC
     Outcomes of SARS-CoV-2 Infection in Patients with Chronic Liver Disease and Cirrhosis: a N3C Study.
     Gastroenterology. 2021 Jul 17. pii: S0016-5085(21)03244.
     PubMed     Abstract available
     
     
     
198. YE P, Miao H, Chen Y
     An unusual case of symptomatic portal hypertension.
     Gastroenterology. 2021 Jul 16. pii: S0016-5085(21)03253.
     PubMed    
     
     
     
199. MAAN R, Darwish Murad S, van der Meer AJ
     Letter to the Editor: Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: A Meta-analysis of Individual Patient Data.
     Gastroenterology. 2021;161:371-372.
     PubMed    
     
     
     
200. LI L, Liu C, Qi X
     Letter to the Editor: Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: A Meta-analysis of Individual Patient Data.
     Gastroenterology. 2021;161:370-371.
     PubMed    
     
     
     
201. PARIKH ND, Chung GS, Mellinger J, Blanchette JG, et al
     Alcohol Policies and Alcohol-related Liver Disease Mortality.
     Gastroenterology. 2021;161:350-352.
     PubMed    
     
     
     
202. RUSTGI VK, Li Y, Gupta K, Minacapelli CD, et al
     Bariatric Surgery Reduces Cancer Risk in Adults With Nonalcoholic Fatty Liver Disease and Severe Obesity.
     Gastroenterology. 2021;161:171-184.
     PubMed     Abstract available
     
     
     
203. SURAPANENI PK, Mills K, Renelus BD
     A Rare Complication of Sickle Cell Anemia.
     Gastroenterology. 2021;161:45-46.
     PubMed    
     
     
     June 2021
204. CHIANG HC, Chien SC, Lin YJ
     Pleural effusion with gastric ulcer.
     Gastroenterology. 2021 Jun 26. pii: S0016-5085(21)03176.
     PubMed    
     
     
     
205. TSOI AH, Garg M, Tsoi EH
     Peptic ulcer disease: an unusual presentation of a common problem.
     Gastroenterology. 2021 Jun 26. pii: S0016-5085(21)03174.
     PubMed    
     
     
     
206. VALENTI L, Mondelli M, Colombo M
     Liver field during immunotherapy of hepatocellular carcinoma: some like it hot.
     Gastroenterology. 2021 Jun 24. pii: S0016-5085(21)03165.
     PubMed    
     
     
     
207. LI H, Liu H
     Recurrent Epistaxis and Diffuse Hepatic and Splenic Vascular Malformations.
     Gastroenterology. 2021 Jun 8. pii: S0016-5085(21)03091.
     PubMed    
     
     
     
208. MEDICI V
     Expanding the Diagnostic Toolkit of Wilson Disease with ATP7B Peptides.
     Gastroenterology. 2021;160:2249-2251.
     PubMed    
     
     
     
209. SU P, Hong J, Li T
     An Uncommon Lesion of the Liver.
     Gastroenterology. 2021;160:2258-2260.
     PubMed    
     
     
     
210. COLLINS CJ, Yi F, Dayuha R, Duong P, et al
     Direct Measurement of ATP7B Peptides Is Highly Effective in the Diagnosis of Wilson Disease.
     Gastroenterology. 2021;160:2367-2382.
     PubMed     Abstract available
     
     
     May 2021
211. EDWARDS LA, Goldenberg SD, Shawcross DL
     Meeting the challenge of antimicrobial resistance in cirrhosis: the invisible threat that lies within.
     Gastroenterology. 2021 May 25. pii: S0016-5085(21)03065.
     PubMed    
     
     
     
212. GARCIA-TSAO G, Abraldes JG
     Non-selective beta-blockers in compensated cirrhosis: Preventing variceal hemorrhage or preventing decompensation?
     Gastroenterology. 2021 May 11. pii: S0016-5085(21)02972.
     PubMed    
     
     
     
213. PERRY IE, Azam MU, Yap JE
     Carcinoma Camouflage.
     Gastroenterology. 2021;160:1940-1942.
     PubMed    
     
     
     
214. SHEN C, Zong Z, Xu N
     "Malignant" Liver Cysts Cause Liver Failure and Recurrence.
     Gastroenterology. 2021;160:e7-e9.
     PubMed    
     
     
     
215. NAYAK LJ, Sondhi AR, Westerhoff M
     History!
     Gastroenterology. 2021;160:e5-e6.
     PubMed    
     
     
     
216. HA NB, Wang CW, El-Nachef N
     An Unusual Mechanical Cause of Upper Gastrointestinal Hemorrhage.
     Gastroenterology. 2021;160:e1-e4.
     PubMed    
     
     
     April 2021
217. PACK M
     Model Organisms Help Define the ABCs of Neonatal Cholestasis.
     Gastroenterology. 2021 Apr 15. pii: S0016-5085(21)00636.
     PubMed    
     
     
     
218. SHAMSADDINI A, Gillevet PM, Acharya C, Fagan A, et al
     Impact of Antibiotic Resistance Genes in Gut Microbiome of Patients with Cirrhosis.
     Gastroenterology. 2021 Apr 12. pii: S0016-5085(21)00634.
     PubMed     Abstract available
     
     
     
219. SHEEHAN JL, Brandler J, Rice MD
     A Case of Recurrent Hepatic Abscesses.
     Gastroenterology. 2021 Apr 8. pii: S0016-5085(21)00627.
     PubMed    
     
     
     
220. PONZIANI FR, Nesci A, Del Zompo F, Santopaolo F, et al
     Correlation Between Liver Function Tests Abnormalities and Interleukin-6 Serum Levels in Patients With SARS-CoV-2 Infection.
     Gastroenterology. 2021;160:1891-1893.
     PubMed    
     
     
     
221. KHAN MU, Mushtaq K, Alkaabi SR
     Acute-on-Chronic Liver Failure: Possibly the Main Culprit of Increased Mortality in COVID-19 Patients with Liver Disease.
     Gastroenterology. 2021;160:1894-1895.
     PubMed    
     
     
     
222. VERMA N, Duseja A, Singh V
     Impact of Preexisting Chronic Liver Disease on the Outcome of Patients With COVID-19 Disease.
     Gastroenterology. 2021;160:1893-1894.
     PubMed    
     
     
     
223. LUUKKONEN PK, Salomaa V, Aberg F
     The Pi *MZ Allele in Alpha-1 Antitrypsin Increases Liver-Related Outcomes in a Population-Based Study.
     Gastroenterology. 2021;160:1874-1875.
     PubMed    
     
     
     
224. JAMIALAHMADI O, Mancina RM, Ciociola E, Tavaglione F, et al
     Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease.
     Gastroenterology. 2021;160:1634-1646.
     PubMed     Abstract available
     
     
     March 2021
225. ASSELTA R, Paraboschi EM, Gerussi A, Cordell HJ, et al
     X chromosome contribution to the genetic architecture of primary biliary cholangitis.
     Gastroenterology. 2021 Mar 3. pii: S0016-5085(21)00466.
     PubMed     Abstract available
     
     
     
226. CASADEI-GARDINI A, Cascinu S, Colombo M
     Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma: Ready for Prime Time?
     Gastroenterology. 2021;160:1423-1424.
     PubMed    
     
     
     
227. GOLDBERG D, Ross-Driscoll K, Lynch R
     County Differences in Liver Mortality in the United States: Impact of Sociodemographics, Disease Risk Factors, and Access to Care.
     Gastroenterology. 2021;160:1140-1150.
     PubMed     Abstract available
     
     
     
228. KOBAYASHI H, Gieniec KA, Wright JA, Wang T, et al
     The Balance of Stromal BMP Signaling Mediated by GREM1 and ISLR Drives Colorectal Carcinogenesis.
     Gastroenterology. 2021;160:1224-1239.
     PubMed     Abstract available
     
     
     
229. PRZYBYSZEWSKI EM, Deshpande V, Uchida AM
     An Unsuspected Cause of Rectal Bleeding.
     Gastroenterology. 2021;160:e1-e2.
     PubMed    
     
     
     February 2021
230. YOUNOSSI ZM, Corey KE, Lim JK
     AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review.
     Gastroenterology. 2021;160:912-918.
     PubMed     Abstract available
     
     
     
231. SHINOZAWA T, Kimura M, Cai Y, Saiki N, et al
     High-Fidelity Drug-Induced Liver Injury Screen Using Human Pluripotent Stem Cell-Derived Organoids.
     Gastroenterology. 2021;160:831-846.
     PubMed     Abstract available
     
     
     
232. NASSANI N, Melitas C, Villa E
     An Unusual Cause of Watery Diarrhea.
     Gastroenterology. 2021;160:671-674.
     PubMed    
     
     
     January 2021
233. BHAT S, Farraye FA, Hayney MS, Caldera F, et al
     How to Implement a Successful Vaccination Program in Outpatient Gastroenterology Practices: A Focus on Patients with Inflammatory Bowel Disease and Chronic Liver Disease.
     Gastroenterology. 2021 Jan 15. pii: S0016-5085(21)00093.
     PubMed    
     
     
     
234. ACHARYA C, Bajaj JS
     Chronic Liver Diseases and the Microbiome-Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease.
     Gastroenterology. 2021;160:556-572.
     PubMed     Abstract available
     
     
     
235. NICOARA-FARCAU O, Han G, Rudler M, Angrisani D, et al
     Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data.
     Gastroenterology. 2021;160:193-205.
     PubMed     Abstract available
     
     
     December 2020
236. VAN DIJK M, Weehuizen TAF, Lowenberg M
     A rare cause of acute abdominal pain after endoscopic retrograde cholangiopancreaticography.
     Gastroenterology. 2020 Dec 17. pii: S0016-5085(20)35559.
     PubMed    
     
     
     
237. ARVIND A, Osganian SA, Sjoquist JA, Corey KE, et al
     Epoxygenase-Derived Epoxyeicosatrienoic Acid Mediators Are Associated With Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Fibrosis.
     Gastroenterology. 2020;159:2232-2234.
     PubMed    
     
     
     November 2020
238. NOUREDDIN M, Jones C, Alkhouri N, Gomez EV, et al
     Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis.
     Gastroenterology. 2020;159:1985-1987.
     PubMed    
     
     
     
239. XANTHAKOS SA, Lavine JE, Yates KP, Schwimmer JB, et al
     Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice.
     Gastroenterology. 2020;159:1731-1751.
     PubMed     Abstract available
     
     
     
240. LANG S, Demir M, Martin A, Jiang L, et al
     Intestinal Virome Signature Associated With Severity of Nonalcoholic Fatty Liver Disease.
     Gastroenterology. 2020;159:1839-1852.
     PubMed     Abstract available
     
     
     October 2020
241. VERBOVEN E, Moya IM, Sansores-Garcia L, Xie J, et al
     Regeneration Defects in Yap and Taz Mutant Mouse Livers are Caused by Bile Duct Disruption and Cholestasis.
     Gastroenterology. 2020 Oct 27. pii: S0016-5085(20)35324.
     PubMed     Abstract available
     
     
     
242. DOUGAN M, Wang Y, Rubio-Tapia A, Lim JK, et al
     AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor (ICI) Colitis and Hepatitis: Expert Review.
     Gastroenterology. 2020 Oct 17. pii: S0016-5085(20)35282.
     PubMed     Abstract available
     
     
     
243. ASEEM SO, Jalan-Sakrikar N, Chi C, Navarro-Corcuera A, et al
     Epigenomic Evaluation of Cholangiocyte TGFbeta Signaling Identifies a Selective Role for Histone 3 Lysine 9 Acetylation in Biliary Fibrosis.
     Gastroenterology. 2020 Oct 12. pii: S0016-5085(20)35245.
     PubMed     Abstract available
     
     
     
244. DE VRIES E, Bolier R, Goet J, Pares A, et al
     Fibrates for itch (FITCH) in fibrosing cholangiopathies: a double blind, randomized, placebo-controlled trial.
     Gastroenterology. 2020 Oct 5. pii: S0016-5085(20)35226.
     PubMed     Abstract available
     
     
     
245. ROMEO S
     MARC1 and HNRNPUL1: Two Novel Players in Alcohol-related Liver Disease.
     Gastroenterology. 2020;159:1231-1232.
     PubMed    
     
     
     
246. RAMLI MNB, Lim YS, Koe CT, Demircioglu D, et al
     Human Pluripotent Stem Cell-Derived Organoids as Models of Liver Disease.
     Gastroenterology. 2020;159:1471-1486.
     PubMed     Abstract available
     
     
     September 2020
247. VILAR-GOMEZ E, Sookoian S, Pirola CJ, Liang T, et al
     ADH1B *2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption.
     Gastroenterology. 2020;159:929-943.
     PubMed     Abstract available
     
     
     
248. CHAI C, Cox B, Yaish D, Gross D, et al
     Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.
     Gastroenterology. 2020;159:999-1014.
     PubMed     Abstract available
     
     
     
249. WANG Y, Pan Y, Zhou Z
     An Unusual Cause of Fever in a Man With a Liver Mass.
     Gastroenterology. 2020;159:842-844.
     PubMed    
     
     
     August 2020
250. JANSSON-KNODELL CL, Walker MJ, Fischer M
     Pancytopenia in a Young Male Patient with Inflammatory Bowel Disease.
     Gastroenterology. 2020 Aug 7. pii: S0016-5085(20)35027.
     PubMed    
     
     
     
251. NABI O, Lacombe K, Boursier J, Mathurin P, et al
     Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in General Population: the French Nationwide NASH-CO Study.
     Gastroenterology. 2020;159:791-793.
     PubMed    
     
     
     
252. SCHNEIDER CV, Hamesch K, Gross A, Mandorfer M, et al
     Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi *Z Variant of AAT (Pi *MZ vs Pi *ZZ genotype) and Noncarriers.
     Gastroenterology. 2020;159:534-548.
     PubMed     Abstract available
     
     
     
253. GUPTA V, Gupta I, Park J, Bram Y, et al
     Hedgehog Signaling Demarcates a Niche of Fibrogenic Peribiliary Mesenchymal Cells.
     Gastroenterology. 2020;159:624-638.
     PubMed     Abstract available
     
     
     
254. NAUDIN CR, Maner-Smith K, Owens JA, Wynn GM, et al
     Lactococcus lactis Subspecies cremoris Elicits Protection Against Metabolic Changes Induced by a Western-Style Diet.
     Gastroenterology. 2020;159:639-651.
     PubMed     Abstract available
     
     
     June 2020
255. RUETHER DF, Menz A, Manthey CF
     A Dishevelled Man with Inflammatory Bowel Disease and Signs of Infection.
     Gastroenterology. 2020 Jun 5. pii: S0016-5085(20)34749.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.